RemSleep Holdings (RMSL) Interest Coverage Ratio Growth (1y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 66.99% |
| 10 | RemSleep Holdings | - | - | -7,636.00 | 41.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.96% |
| Sep 30, 2025 | -482.03% |
| Jun 30, 2025 | 89.76% |
| Mar 31, 2025 | 61.25% |
| Jun 30, 2024 | 92.64% |
| Mar 31, 2024 | 89.39% |
| Jun 30, 2023 | -1,763.86% |
| Mar 31, 2023 | -4,599.40% |
| Dec 31, 2022 | -17,227.52% |
| Sep 30, 2022 | -15,840.07% |
| Jun 30, 2022 | -1,063.05% |
| Mar 31, 2022 | -57.28% |
| Dec 31, 2021 | 68.86% |
| Sep 30, 2021 | 14.38% |
| Jun 30, 2021 | 29.29% |
| Mar 31, 2021 | -14.50% |
| Dec 31, 2020 | -113.78% |
| Sep 30, 2020 | 54.26% |
| Jun 30, 2020 | 97.33% |
| Mar 31, 2020 | 89.61% |
| Dec 31, 2019 | -100.55% |
| Sep 30, 2019 | 99.24% |
| Jun 30, 2019 | 93.92% |
| Mar 31, 2019 | 97.97% |
| Dec 31, 2018 | 184.64% |
| Sep 30, 2018 | 34.33% |
| Jun 30, 2018 | -114.71% |
| Dec 31, 2014 | 49.16% |